• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES NOVAFLEX+ DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES NOVAFLEX+ DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9355FS23
Device Problems Burst Container or Vessel (1074); Fracture (1260); Leak/Splash (1354); Difficult to Remove (1528)
Patient Problems Calcium Deposits/Calcification (1758); Injury (2348); Device Embedded In Tissue or Plaque (3165)
Event Date 08/29/2018
Event Type  malfunction  
Manufacturer Narrative
Udi (b)(4).The device was not returned to edwards lifesciences for evaluation, as it was discarded at the facility. per the instructions for use (ifu), mechanical failure of delivery system, and/or accessories is a potential risk of the tavr procedure.According to the ifu cardiovascular complications, including perforation or dissection of vessels which may require intervention, are potential adverse events associated with the transfemoral tavr procedure.Transcatheter delivery balloon burst complaints have been previously investigated by edwards lifesciences and documented in technical summary.A detailed root cause analysis revealed that it is very unlikely that a product defect contributes to this type of event.There are extensive manufacturing inspections in place to prevent this type of malfunction (visual and dimensional inspections, leak testing, and functional balloon burst testing performed to every manufactured lot).The thv delivery system balloons are subject to increased risk of burst due to contact with a highly calcified annulus.Analysis revealed that these types of ruptures are typically caused by puncture from calcium on the native aortic valve when the inflated delivery system balloon comes in contact with the native annular calcification at full inflation/deployment.In addition, the balloon burst increases the possibility of an obstacle (i.E.Patient's anatomy or sheath tip) interfering with retraction of the balloon/balloon material.The physician training manual provides the following instruction: if the inflation balloon leaks or bursts, do not use excessive force when removing the balloon.In this case, per report patient factors (sharp piece of calcium) likely caused the balloon burst, which may have in turn caused the withdrawal difficulty damaging the sheath and resulting in artery trauma.   the ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required at this time.
 
Event Description
As reported by our affiliates in (b)(6), during the post dilation of the 23mm sapien xt valve due to perivalvular leak (pvl), by left side tf approach in aortic position, the balloon burst on a sharp piece of calcium.It was not possible to retrieve the balloon back into the e-sheath causing severe damage to the e-sheath and subsequently an artery trauma.However, it was managed to get the delivery system and sheath out of the patient through the access site.Afterwards the vascular surgeon surgically repaired the vessel.Despite the complications, the pvl was reduced to mild and the patient was stable post procedure.The access vessel minimum luminal diameter measured 6.0 mm with moderate calcification and tortuosity.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVAFLEX+ DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key7890703
MDR Text Key120978658
Report Number2015691-2018-03852
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
PMA/PMN Number
P130009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/02/2019
Device Model Number9355FS23
Device Catalogue Number9355FS23A
Device Lot Number61093020
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/29/2018
Initial Date FDA Received09/19/2018
Supplement Dates Manufacturer Received07/23/2020
Supplement Dates FDA Received10/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-